Trial Profile
Intravitreal Injection Using 33-gauge Versus 30-gauge Needles: Comparison of Patients' Experience
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration; Diabetic macular oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 21 Jul 2017 Status changed from recruiting to completed.
- 06 Feb 2017 New trial record